Dopharma and RIPAC-LABOR join forces

As a part of Dopharma’s mission to “Healthy Livestock” the family owned Dutch company extended their efforts in providing diagnostics and vaccines for livestock by acquiring shares in the German family owned company RIPAC-LABOR, specialist in the development and production of autogenous vaccines.

Read the official press release